You are here

Article info

Article menu
XML
Epidemiology
Immunomodulatory therapies for SARS-CoV-2 infection: a systematic literature review to inform EULAR points to consider

Authors

  • Alessia Alunno Rheumatology Unit, Department of Medicine, University of Perugia, Perugia, Italy PubMed articlesGoogle scholar articles
  • Aurélie Najm Institute of Infection, Immunity and Inflammation, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK PubMed articlesGoogle scholar articles
  • Xavier Mariette Department of Rheumatology, Université Paris-Saclay, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, INSERM UMR1184, Le Kremlin Bicêtre, France PubMed articlesGoogle scholar articles
  • Gabriele De Marco Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, Leeds, UK The NIHR Leeds Biomedical Research Centre, Chapel Allerton Hospital, Leeds, UK PubMed articlesGoogle scholar articles
  • Jenny Emmel Library & Evidence Research Centre, Medical Education, Leeds Teaching Hospitals NHS Trust, Leeds, UK PubMed articlesGoogle scholar articles
  • Laura Mason Library & Evidence Research Centre, Medical Education, Leeds Teaching Hospitals NHS Trust, Leeds, UK PubMed articlesGoogle scholar articles
  • Dennis G McGonagle Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, Leeds, UK The NIHR Leeds Biomedical Research Centre, Chapel Allerton Hospital, Leeds, UK PubMed articlesGoogle scholar articles
  • Pedro M Machado Department of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS Trust, London, UK Centre for Rheumatology & Department of Neuromuscular Diseases, University College London, London, UK National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre (BRC), University College London Hospitals (UCLH) NHS Foundation Trust, London, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Alessia Alunno, Rheumatology Unit, Department of Medicine, University of Perugia, 06123 Perugia, Umbria, Italy; alessia.alunno82{at}gmail.com
View Full Text

Citation

Alunno A, Najm A, Mariette X, et al
Immunomodulatory therapies for SARS-CoV-2 infection: a systematic literature review to inform EULAR points to consider
Annals of the Rheumatic Diseases 2021;80:803-815.

Publication history

  • Received December 15, 2020
  • Revised January 24, 2021
  • Accepted January 27, 2021
  • First published February 15, 2021.
Online issue publication 
November 15, 2022

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.